Cell proliferation pathways (E2F targets, MYC targets, Mitotic signaling) were also consistently upregulated in tumor-derived T lymphocytes, in line with the observed general expansion of T cells (Fig. 1d). This evidence concerns the gene MYC and neoplasm.